Online Inquiry
Cat.#: ACPP-1307
| Despition | NPY2R Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1327 | Dopamine Receptor D1 Blocking Peptide (AC1327) | 250 µg | inquiry |
| ACPP-1709 | Human GPC4 Protein (AC1709) | 2 µg | inquiry |
| ACPP-1116 | Recombinant Human L1CAM Protein (6×His Tag) (AC1116) | 50 µg | inquiry |
| ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
| ACPP-1624 | Human EFNA1 Protein (AC1624) | 5 µg | inquiry |
| ACPP-1275 | Usherin Blocking Peptide (AC1275) | 250 µg | inquiry |
| ACPP-1438 | Human NDRG2 Protein (AC1438) | 5 µg | inquiry |
| ACPP-1507 | Human SDC4 Protein (AC1507) | 2 µg | inquiry |
| ACPP-1431 | Human CNTFR Protein (AC1431) | 5 µg | inquiry |
| ACPP-1610 | Mouse MANF Protein (AC1610) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.